SDIC
CYTK icon

South Dakota Investment Council’s Cytokinetics CYTK Stock Holding History

South Dakota Investment Council’s Portfolio CYTK Stock Details CYTK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-8,021
Closed -$670K – 599
2023
Q4 		$670K Sell
8,021
-33,700
-81% -$1.22M 0.01% 509
2023
Q3 		$1.23M Hold
41,721
– – 0.03% 410
2023
Q2 		$1.36M Sell
41,721
-5,091
-11% -$188K 0.03% 418
2023
Q1 		$1.65M Sell
46,812
-30,500
-39% -$1.24M 0.04% 389
2022
Q4 		$3.54M Hold
77,312
– – 0.08% 215
2022
Q3 		$3.75M Hold
77,312
– – 0.09% 199
2022
Q2 		$3.04M Sell
77,312
-50,471
-39% -$2.03M 0.07% 246
2022
Q1 		$4.7M Sell
127,783
-102,577
-45% -$3.64M 0.09% 194
2021
Q4 		$10.5M Sell
230,360
-14,410
-6% -$556K 0.18% 122
2021
Q3 		$8.75M Buy
244,770
+14,100
+6% +$415K 0.16% 137
2021
Q2 		$4.57M Sell
230,670
-47,347
-17% -$1.11M 0.08% 218
2021
Q1 		$6.47M Sell
278,017
-21,081
-7% -$450K 0.11% 178
2020
Q4 		$6.21M Buy
299,098
+75,400
+34% +$1.38M 0.11% 168
2020
Q3 		$4.84M Sell
223,698
-6,900
-3% -$161K 0.11% 173
2020
Q2 		$5.43M Sell
230,598
-24,764
-10% -$464K 0.13% 154
2020
Q1 		$3.01M Sell
255,362
-12,802
-5% -$163K 0.08% 193
2019
Q4 		$2.85M Sell
268,164
-36,710
-12% -$377K 0.06% 263
2019
Q3 		$3.47M Buy
304,874
+2,910
+1% +$36.5K 0.07% 252
2019
Q2 		$3.4M Sell
301,964
-170,994
-36% -$1.65M 0.07% 212
2019
Q1 		$3.83M Buy
472,958
+25,300
+6% +$186K 0.08% 193
2018
Q4 		$2.83M Hold
447,658
– – 0.07% 219
2018
Q3 		$4.41M Buy
447,658
+181,458
+68% +$1.46M 0.1% 177
2018
Q2 		$2.21M Buy
+266,200
New +$2.22M 0.05% 294

Other funds holding CYTK

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return

South Dakota Investment Council's CYTK Position: Q1 2024 in Review

South Dakota Investment Council sold out of Cytokinetics (CYTK) in Q1 2024, closing a stake of 8,021 shares — an estimated $670K sold.

South Dakota Investment Council first reported a position in CYTK in Q2 2018 and held it in 23 quarters. The position peaked at $10.5M in Q4 2021. 390 funds tracked by Wall St. Rank hold CYTK as of Q1 2024.

  • South Dakota Investment Council reported no remaining Cytokinetics position as of Q1 2024 after selling out during the quarter.
  • South Dakota Investment Council sold 8,021 Cytokinetics shares in Q1 2024, an estimated $670K.
  • South Dakota Investment Council first reported a position in Cytokinetics in Q2 2018 and held it in 23 quarters.
  • South Dakota Investment Council's Cytokinetics position peaked at $10.5M in Q4 2021.
  • 390 funds tracked by Wall St. Rank held Cytokinetics as of Q1 2024.

Based on South Dakota Investment Council's 13F filing for Q1 2024, filed 2 May 2024.